Recomendaciones sobre el tratamiento farmacológico y quirúrgico de la obesidad en pediatría-Reference-Cited by-同舟云学术

Recomendaciones sobre el tratamiento farmacológico y quirúrgico de la obesidad en pediatría

Published:2023 Issue:S1 Volume:90 Page:s41-47
ISSN:0035-0052
Container-title:Revista Mexicana de Pediatría
language:es
Short-container-title:

Author:

Peralta-Cortázar Catalina,López-Beltrán Ana Laura,Medina-Serrano Julio Manuel,Rivera-Hernández Aleida de Jesús,Mejenes-Álvarez Susana Amada,Mejía-Carmona Luz Elena,Maldonado-Ramírez Martha Cristina,Saltigeral-Simental Patricia,Correa-Flores Manuel Ángel,Padilla-Rojas Mitchel Martín,Zurita-Cruz Jessie

Publisher

GRAPHIMEDIC SA DE CV

Reference39 articles.

1. Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017; 102(3): 709-757. doi: 10.1210/jc.2016-2573.

2. Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023; 151(2): e2022060640. doi: 10.1542/peds.2022-060640.

3. Mead E, Atkinson G, Richter B, Metzendorf MI, Baur L, Finer N et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016; 11(11): CD012436. doi: 10.1002/14651858.CD012436.

4. Bouza C, López-Cuadrado T, Gutierrez-Torres LF, Amate J. Efficacy and safety of metformin for treatment of overweight and obesity in adolescents: an updated systematic review and meta-analysis. Obes Facts. 2012; 5(5): 753-765. doi: 10.1159/000345023.

5. Sun J, Wang Y, Zhang X, He H. The effects of metformin on insulin resistance in overweight or obese children and adolescents: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019; 98(4): e14249. doi: 10.1097/MD.0000000000014249.